2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound
Language English Country United States Media print-electronic
Document type Journal Article
PubMed
28039083
DOI
10.1016/j.freeradbiomed.2016.12.042
PII: S0891-5849(16)31143-1
Knihovny.cz E-resources
- Keywords
- 2,3-dehydrosilybin A/B, Anti-aggregation, Anti-aging, Anti-oxidation, DAF-16, FGT-1,
- MeSH
- Cell Line MeSH
- Caenorhabditis elegans MeSH
- CHO Cells MeSH
- Cricetulus MeSH
- Longevity drug effects MeSH
- Cricetinae MeSH
- Humans MeSH
- Protective Agents pharmacology MeSH
- Oxidative Stress MeSH
- Protein Aggregation, Pathological prevention & control MeSH
- Drug Evaluation, Preclinical MeSH
- Caenorhabditis elegans Proteins metabolism MeSH
- Glucose Transport Proteins, Facilitative metabolism MeSH
- Silybin MeSH
- Silymarin pharmacology MeSH
- Cell Survival drug effects MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- FGT-1 protein, C elegans MeSH Browser
- Protective Agents MeSH
- Caenorhabditis elegans Proteins MeSH
- Glucose Transport Proteins, Facilitative MeSH
- Silybin MeSH
- Silymarin MeSH
Aging is an unavoidable process characterized by gradual failure of homeostasis that constitutes a critical risk factor for several age-related disorders. It has been unveiled that manipulation of various key pathways may decelerate the aging progression and the triggering of age-related diseases. As a consequence, the identification of compounds, preferably natural-occurring, administered through diet, with lifespan-extending, anti-aggregation and anti-oxidation properties that in parallel exhibit negligible side-effects is the main goal in the battle against aging. Here we analyze the role of 2,3-dehydrosilybin A/B (DHS A/B), a minor component of silymarin used in a plethora of dietary supplements. This flavonolignan is well-known for its anti-oxidative and neuroprotective properties, among others. We demonstrate that DHS A/B confers oxidative stress resistance not only in human primary cells but also in the context of a multi-cellular aging model, namely Caenorhabditis elegans (C. elegans) where it also promotes lifespan extension. We reveal that these DHS A/B outcomes are FGT-1 and DAF-16 dependent. We additionally demonstrate the anti-aggregation properties of DHS A/B in human cells of nervous origin but also in nematode models of Alzheimer's disease (AD), eventually leading to decelerated progression of AD phenotype. Our results identify DHS A/B as the active component of silymarin extract and propose DHS A/B as a candidate anti-aging and anti-aggregation compound.
References provided by Crossref.org
Silymarin Dehydroflavonolignans Chelate Zinc and Partially Inhibit Alcohol Dehydrogenase
Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners
Complex Evaluation of Antioxidant Capacity of Milk Thistle Dietary Supplements